21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#3902FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE
#3903Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
#3904ANTI-PD-L1 ANTIBODIES AND ARTICLES OF MANUFACTURE
#3905METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY
#3906METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO TREAT INFECTION RESULTING FROM T-CELL DYSFUNCTION
#3907Proteases for Degrading Gluten
#3908COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#3909Boswellia oil, its fractions and compositions for enhancing brain function
#3910Combination therapy and methods for treatment and prevention of hyperproliferative diseases
#3911USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS
#3912IMMUNITY BOOSTING GUM
#3913Catheter-Based Delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
#3914Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
#3915Treatment of pain with topical diclofenac compounds
#3916Composition for Preventing or Treating Rotavirus Infection Comprising Licorice Extract
#3917Isoform of bruton's tyrosine kinase (BTK) protein
#3918ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN
#3919NEW ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN
#3920COMPOSITION FOR TREATING ATHEROSCLEROSIS AND A PREPARATION METHOD THEREOF
#3921PHARMACEUTICAL COMPOSITION COMPRISING GEMFIBROZIL AND CYP2C8 AND/OR OATP SUBSTRATE DRUG SUCH AS REPAGLINIDE
#3922ORAL SUSTAINED RELEASE FORMULATION OF HUPERZINE A
#3923JAK PI3K/mTOR combination therapy
#3924Deuterium-enriched pyrimidine compounds and derivatives
#3925Compositions for treating cognitive disorders
#3926Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
#3927Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
#3928Method of treating vitamin Bdeficiency
#3929Combination of drugs with protein-binding prodrugs
#3930Method of treatment using α-1-adrenergic agonist compounds
#3931PHARMACEUTICAL COMPOSITIONS FOR TREATING DEPRESSION AND ANXIETY
#3932METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF
#3933Cytokine containing compositions
#3934Methods For Treating Congestive Heart Failure
#3935PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF DIABETES TYPE 2 PATIENTS
#3936Method for sensitizing cancer stem cells to cancer therapy
#3937Natural—topical analgesic and anti-inflammatory composition
#3938Anti-oxidant herbal composition
#3939Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
#3940Methods for inhibiting the activation of immune cells
#3941Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine
#3942DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE REINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#3943ARGON-BASED INHALABLE GASEOUS MEDICAMENT AGAINST PERIPHERAL ORGAN DEFICIENCIES OR FAILURES
#3944MEDICINAL COMPOSITIONS AND METHOD FOR TREATMENT OF URINARY TRACT INFECTIONS
#3945Sodium channel blocker for treatment of loss of superficial sensitivity
#3946Viral Immunogenic Compositions
#3947Metal entrapped bioactive composites
#3948Compositions for reduction of side effects
#3949NETI-POT PACKET MIXTURE
#3950Treatment of IgE-mediated disease
#3951STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#3952COMPOSITIONS AND METHODS FOR REVERSING CORTICOSTEROID RESISTANCE OR TREATING RESPIRATORY INFECTIONS
#3953Predicting response to a HER inhibitor
#3954ECZEMA TREATMENT
#3955POXVIRAL ONCOLYTIC VECTORS
#3956Leukotoxin E/D as a new anti-inflammatory agent and microbicide
#3957Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment
#3958METHOD TO MITIGATE INJURY FROM RADIATION EXPOSURE
#3959COMBINATION FOR THE TREATMENT OF RADIATION- OR CHEMOTHERAPY-INDUCED MUCOSITIS
#3960Rosacea treatments and kits for performing them
#3961METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY
#3962Medical device with coating that promotes endothelial cell adherence
#3963Felbinac-containing transdermally absorbable preparation
#3964TREATMENT OF MULTIPLE SCLEROSIS
#3965Virus-inactivating composition containing low-molecular weight compound and arginine
#3966Process for selective extraction of bioactive and bioavailable cinnamon polyphenols and procyanidin oligomers and a stable composition thereof
#3967Stable Anti-inflammatory Solutions for Injection
#3968Compositions and Methods for Preventing Joint Destruction in Osteoarthritis
#3969PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#3970COMBINATION OF ORGANIC COMPOUNDS
#3971sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS
#3972COMBINATION COMPRISING A CYCLIN DEPENDENT KINASE 4 OR CYCLIN DEPENDENT KINASE (CDK4/6) INHIBITOR FOR TREATING CANCER
#3973COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#3974Pharmaceutical composition comprising metformin and rosuvastatin
#3975Crystallization method and bioavailability
#3976Nucleoside phosphonate salts
#3977USE OF AN ACTIVE INGREDIENT COMBINATION THAT CONTAINS HYDROXYSTILBENE FOR PREVENTING AND/OR TREATING DISEASES
#3978Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
#3979Compositions for treating the integument
#3980Immediate release tablet formulations
#3981METHOD FOR INCREASING LACTOSE TOLERANCE IN MAMMALS EXHIBITING LACTOSE INTOLERANCE
#3982Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound
#3983Local administration of gallium compositions to treat pain
#3984Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases
#3985Combination therapy for treating breast cancer
#3986Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
#3987COLD TREATMENT
#3988PHARMACEUTICAL COMPOSITIONS
#3989Reverse hexagonal mesophases (H) and uses thereof
#3990SIMULTANEOUS CO-TREATMENT OF PHYSICAL AND MENTAL SYMPTOMS RELATED TO SEVERE MENTAL DISORDERS BY A SPECIALLY FERMENTED SOY FORMULATION (FSWW08)
#3991Bile Acid Recycling Inhibitors for Treatment of Pancreatitis
#3992Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
#3993Use of proteases for gluten intolerance
#3994Natural compositions and methods of promoting wound healing
#3995THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION
#3996Melanin modification compositions and methods of use
#3997Cationic Steroid Antimicrobial Compositions and Methods of Use
#3998ISOTOPOLOGUES OF 4-[9-(TETRAHYDRO-FURAN-3-YL)-8-(2,4,6-TRIFLUORO-PHENYLAMINO)-9H-PURIN-2-YLAMINO]-CYCLOHEXAN-1-OL
#3999Class I anti-CEA antibodies and uses thereof
#4000Relay link HARQ operation
#4001POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORS
#4002Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof
#4003NOVEL NIDDM REGIMEN
#4004Treatment of osteoporosis
#4005Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration
#4006USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY
#4007QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#4008QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#4009Non-sedating antihistamine injection formulations and methods of use thereof
#4010METHOD FOR THE TREATMENT AND/OR PREVENTION OF ORAL ALLERGIC SYMPTIONS OF THE LIPS DUE TO ORAL CONTACT WITH A FOOD ALLERGEN
#4011SPECIAL COMPOSITION FOR THE USE THEREOF AS A DRUG
#4012TOPICAL TREATMENTS FOR PAIN
#40133-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma
#4014Combination of azelastine and mometasone for nasal administration
#4015Combination of azelastine and ciclesonide for nasal administration
#4016Methods and compositions for the treatment of proliferative vascular disorders
#4017Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof
#4018Pleurotus tuber-regium polysaccharide functionalized nano-selenium hydrosol with anti-tumor activity and preparation method thereof
#4019COMPOSITIONS COMPRISING PERFLUOROOCTANOIC ACID
#4020COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#4021Materials and Methods for Prevention and Treatment of Viral Infections
#4022Formulations from derivatives of curcumin, paclitaxel, and aspirin
#4023TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
#4024Formulation containing curcuminoids exhibiting enhanced bioavailability
#4025HCV COMBINATION THERAPY
#4026Isoxazolines for controlling invertebrate pests
#4027METHOD OF IMPLANTING MESENCHYMAL STEM CELLS FOR NATURAL TOOTH REGENERATION IN SURGICALLY PREPARED EXTRACTION SOCKET AND COMPOSITIONS THEREOF
#4028Compositions and methods for the prevention and treatment of metabolic diseases
#4029Synergistic compositions for the treatment of topical viral infections
#4030Composition and manufacturing processes of a toxicity free botanical drug for curative treatment of chronic diseases
#4031Dietary supplement for use in a weight loss program
#4032Materials and method for inhibiting replication protein A and uses thereof
#4033Composition for obesity treatment
#4034Method of treating psoriasis
#4035COMPOSITION AND METHOD FOR TREATING MIGRAINES
#4036Natural tissue scaffolds as tissue fillers
#4037Indicator for oxygen generation
#4038Method of making platelet and poly-beta-1,4-N-acetylglucosamine fiber compositions
#4039Stretch Marks Cream
#4040COMPOSITIONS AND METHODS FOR WOUND TREATMENT
#4041PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION
#4042PHARMACEUTICAL FORMULATION IN THE FORM OF BILAYERED TABLETS COMPRISING HMG-COA REDUCTASE INHIBITOR AND IRBESARTAN
#4043Tamper-resistant tablet providing immediate drug release
#4044Liposomes for Preventing the Spread of HIV
#4045Solid pharmaceutical dosage form of ticagrelor
#4046CO-CRYSTALS OF VENLAFAXINE AND CELECOXIB
#4047FUNCTIONAL BEVERAGE COMPOSITION COMPRISING CHLORELLA AND DEEP SEA WATER
#4048DENDRITIC CELL (DC)-VACCINE THERAPY FOR PANCREATIC CANCER
#4049HMG1 antibody for treating inflammatory conditions
#4050Human antibodies that bind mesothelin, and uses thereof
#4051Human antibodies that bind mesothelin, and uses thereof
#4052Human antibodies that bind mesothelin, and uses thereof
#4053Combination therapy with CD4 lymphocyte depletion and mTOR inhibitors
#4054Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses
#4055Phenylacetic acid compound
#4056COMPOSITION AND METHOD FOR TREATMENT OF BRUISING
#4057ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE
#4058METHODS, PHARMACEUTICAL COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR ADMINISTERING THERAPEUTIC CELLS TO THE ANIMAL CENTRAL NERVOUS SYSTEM
#4059Placental stem cell populations
#4060TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND INTERFERON-BETA
#4061Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside
#4062ANTI-INFLAMMATORY COMPOSITIONS FOR TREATING BRAIN INFLAMMATION
#4063TREATMENT WITH ANTI-VEGF ANTIBODIES
#4064Hepatitis C virus inhibitors
#4065Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
#4066Biofilm treatment
#4067Preparations for effervescent formulations comprising cephalosporin and uses thereof
#4068STATOR IN AN ELECTRIC MOTOR
#4069PHOSPHORUS-CONTAINING COMPOUNDS WITH POLYMERIC CHAINS, AND METHODS OF MAKING AND USING THE SAME
#4070COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE ALLERGIES
#4071Polymorphs of darunavir
#4072FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE
#4073ANAESTHETIC EYE SOLUTION AND METHOD OF USE
#4074Methods and Compositions for Treating Cardiovascular Disorders
#4075Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection
#4076Hyaluronic acid based copolymers
#4077Hyaluronic acid based copolymers
#4078Hyaluronic acid based copolymers
#4079METHODS FOR INHIBITING PRETERM LABOR AND UTERINE CONTRACTILITY DISORDERS AND PREVENTING CERVICAL RIPENING
#4080Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer
#4081Compounds and compositions for treating infection
#4082EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS
#4083Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
#4084Method for improving glucose tolerance in a diabetes type 2 patient of younger than 50 years and having postprandial plasma glucose concentration of at least 14 mmol/L
#4085Calcium preparation and method of production thereof
#4086Expression Modulator For Clock Gene Period
#4087Use of amisulpride as an anti-emetic
#4088Use of amisulpride as an anti-emetic
#4089TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#4090PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#4091ENHANCEMENT OF MAGNESIUM UPTAKE IN MAMMALS
#4092Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula
#4093Controlled release pharmaceutical compositions of tapentadol
#4094COMPOSITIONS CONTAINING SALMETEROL, FLUTICASONE AND CROMOGLICIC ACID
#4095Controlled Release Formulations of Opioids
#4096PHARMACEUTICAL FORMULATIONS OF BISPHOSPHONATE WITH ENHANCED ORAL BIOAVAILABILITY
#4097Antimicrobial anti-chafing chelated silver oxide compound
#4098Expression Modulator For Clock Gene Bmal
#4099Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#4100Combination therapy with antibody-drug conjugates
#4101Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia
#4102Method of treating androgen independent prostate cancer
#4103PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
#4104Method of treating fibroproliferative disorders of the heart and lung
#4105Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
#4106Placental stem cell populations
#4107PROBIOTIC COMPOSITIONS USEFUL FOR TREATMENT OF BIPOLAR DISORDER
#4108Compositions and methods for reducing the incidence of equine digestive disorders
#4109SYSTEMS AND METHODS OF REPLACING INTESTINAL FLORA
#4110Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#4111Methods For Inhibiting Tyrosinase Using an Extract of Laminaria Saccharina
#4112BLOOD CLOTTING COMPOSITION AND METHOD OF USE
#4113FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death
#4114Portable stand and mount for securing a portable media or audio player to a support
#4115Method and apparatus for determining acetabular component positioning
#4116METHODS OF PRODUCING HYBRIDOMAS AND MONOCLONAL ANTIBODIES AND ANTIBODIES PRODUCED THEREBY
#4117HOP ACIDS AS A REPLACEMENT FOR ANTIBIOTICS IN ANIMAL FEED
#4118NUTRITIONAL SUPPLEMENT FOR THE ENHANCEMENT OF MUSCLE PERFORMANCE AND RECOVERY
#4119Compositions comprising amino acids for treating chronic obstructive pulmonary disease
#4120HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF
#4121Method for Improving Exercise and Recovery From Exercise
#4122Method of treatment for mental disorders
#4123Chemical compounds
#4124COMPOSITIONS FOR TOPICAL ADMINISTRATION
#4125Lipid composition for improving brain function
#4126Multicarotenoid beadlets and related method
#4127Compositions and methods for modulating metabolic pathways
#4128Compositions and methods for modulating metabolic pathways
#4129Pain relieving composition
#4130Composition for accelerating change in muscle type
#4131Formulations for treatment of skin disorders
#4132COMPOSITION AND METHOD FOR IMPROVING BRAIN FUNCTION
#4133Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication
#4134Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells
#4135LOW DOSE LITHIUM IN THE TREATMENT OR PROPHYLAXIS OF PARKINSON'S DISEASE
#4136Diane's manna
#4137GASTRIC ACID SECRETION INHIBITING COMPOSITION
#4138Dry powder formulation containing tiotropium for inhalation
#4139Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent
#4140TREATMENT AND/OR PREVENTION OF ORAL ALLERGIC SYMPTOMS CAUSED BY ORAL CONTACT WITH FRUITS AND/OR VEGETABLES
#4141Sustained release intraocular implants and related methods
#4142WOUND HEALING COMPOSITIONS AND ASSOCIATED METHODS
#4143Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
#4144Chemotherapeutic methods and compositions
#4145Treatment of inflammatory diseases
#4146Pharmacological composition whereby statin and COQ10 compounds are enhanced
#4147Stabilised solid compositions of factor VII polypeptides
#4148MULTI-CRITERIA OPTIMIZED DIETARY SUPPLEMENT FORMULATIONS
#4149PLATELET RICH PLASMA FORMULATIONS
#4150COMPOSITIONS AND METHODS FOR INCREASING HEALTH AND REDUCING PATHOGENIC BACTERIA IN ANIMALS
#4151Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
#4152METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#4153Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#4154Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
#4155DRUG DELIVERY DEVICE
#4156DRUG DELIVERY DEVICE
#4157Drug delivery device
#4158DRUG DELIVERY DEVICE
#4159Subcutaneous fat reduction
#4160Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
#4161Methods of Treating Autism
#4162Methods of Treating Fragile X Syndrome
#4163COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISING LDL-C LEVELS IN A SUBJECT ON CONCOMITANT STATIN THERAPY
#4164Compositions and methods for enhanced parvovirus transduction
#4165Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia
#4166Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
#4167Compositions and methods for treating lysosomal disorders
#4168Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
#4169Heterobicyclic carboxamides as inhibitors for kinases
#4170Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
#4171Metalloenzyme inhibitor compounds
#4172Pharmaceutical or veterinary antiviral compositions
#4173Combination steroid and glucocorticoid receptor antagonist therapy
#4174NOVEL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEURODEGENERATIVE OR NEUROVASCULAR DISEASES
#4175INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE
#4176Dosage forms of bisphosphonates
#4177COMBINED USE OF PHOSPHOLIPID AND SULFATE GROUPS-CARRYING POLYSACCHARIDES FOR INHIBITING METASTATIC SPREAD
#4178ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE
#4179LIQUID NUCLEOTIDES/NUCLEOSIDES-CONTAINING PRODUCT
#4180COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE
#4181BIBW 2992 FOR USE IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
#4182Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#4183Compositions and methods for transport across the blood brain barrier
#4184COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION
#4185Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases
#4186Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#4187Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For the Treatment of Psoriasis
#4188Compositions and methods for diagnosis, prognosis and management of malaria
#4189Methods for reducing protein levels in a cell
#4190Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
#4191HERBAL MEDICINAL COMPOSITION AND EXTRACT THEREOF FOR INHIBITING GROWTH OF CANCER CELLS
#4192COMPOSITION FOR A DIETARY SUPPLEMENT FOR THE TREATMENT OF HEMORRHOIDS
#4193HERBAL MEDICINAL COMPOSITION AND EXTRACT THEREOF FOR INHIBITING GROWTH OF CANCER CELLS
#4194Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate
#4195Systems, Methods, and Formulations for Treating Cancer
#4196Visual performance and/or macular pigmentation
#4197FORMULATIONS OF MAZINDOL
#4198CYTOTOXIC THERAPY BY PROTON FLUX MODULATION
#4199Stable compositions of famotidine and ibuprofen
#4200Stable compositions of famotidine and ibuprofen